It has been observed that MEK inhibition induced the accumulation of T cells within the tumor cells and the major histocompatibility complex (MHC) class I upregulation in mouse models, and controlled the synergy and immune checkpoints, promoted sustainable tumor regression 145. This evidence concerns the gene MAP2K7 and neoplasm.